Patents by Inventor Rose Ackermann

Rose Ackermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000887
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: August 4, 2023
    Publication date: January 4, 2024
    Applicant: ABIONYX PHARMA SA
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • Publication number: 20230372441
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: August 4, 2023
    Publication date: November 23, 2023
    Applicant: ABIONYX PHARMA SA
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • Publication number: 20220362336
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: May 27, 2022
    Publication date: November 17, 2022
    Applicant: ABIONYX PHARMA SA
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • Patent number: 11376309
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: July 5, 2022
    Assignee: Cerenis Therapeutics Holding S.A.
    Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
  • Publication number: 20190298800
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: April 29, 2019
    Publication date: October 3, 2019
    Applicant: CERENIS THERAPEUTICS HOLDING S.A.
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • Patent number: 10328119
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: June 25, 2019
    Assignee: CERENIS THERAPEUTICS HOLDING S.A.
    Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
  • Patent number: 10322163
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: June 18, 2019
    Assignee: CERENIS THERAPEUTICS HOLDING S.A.
    Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
  • Publication number: 20160095901
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: October 15, 2015
    Publication date: April 7, 2016
    Applicant: CERENIS THERAPEUTICS HOLDING S.A.
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • Patent number: 9187551
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: November 17, 2015
    Assignee: Cerenis Therapeutics Holding S.A.
    Inventors: Jean-Louis Dasseux, Rose Ackermann
  • Publication number: 20150152164
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: July 17, 2014
    Publication date: June 4, 2015
    Inventors: Jean-Louis DASSEUX, Rose Ackermann, Daniela Carmen Oniciu
  • Publication number: 20140213501
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: December 11, 2013
    Publication date: July 31, 2014
    Applicant: Cerenis Therapeutics Holding S.A.
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • Publication number: 20120232005
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: February 6, 2012
    Publication date: September 13, 2012
    Applicant: Cerenis Therapeutics Holding S.A.
    Inventors: Jean-Louis Dasseux, Daniela Carmen Oniciu, Rose Ackermann